Published 8 hours ago • loading... • Updated 8 hours ago

Healthy Returns: Novo Nordisk’s head of research and development previews the first-ever obesity pill

Summary by CNBC

Novo Nordisk's Martin Holst Lange preveiwed the company's obesity pill, while OpenAI launches new initiative to speed up scientific discovery.

Reposted by

thepress.net

Novo Nordisk's Martin Holst Lange preveiwed the company's obesity pill, while OpenAI launches new initiative to speed up scientific discovery.

8 hours ago·United States

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources2

Leaning Left0Leaning Right0Center2Last Updated5 hours agoBias Distribution

100% Center

100% Center

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

CNBC broke the news in United States 8 hours ago on Wednesday, September 3, 2025.

Sources are mostly out of (0)